Blog Posts, Drug & Target Discovery, Science Blogs, Science content
Anyone can generate thousands of new AI drug candidates. What matters is one great lead.
Blog Posts, Science Blogs, Science content, Synthetic Biology
Programming E. coli to outsmart disease
AI in Drug Discovery, Blog Posts, Science Blogs, Science content
Behind the code: Meet one of the AI scientists revolutionizing antibody design
Events, Past Events
Canaccord Genuity Investor Webinar
Press Releases
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
